Explore By Subject Area   
Return Home
Register Now Menu

PODD: Partnerships in Drug Delivery

Date: Oct 28, 2024 - Oct 29, 2024

Location: Boston, MA

Day 1 October 16, 2023: Monday, October 16, 2023
Showing Events in 1 Track from 08:00am to 09:00am
Morning General Session
8:00AM - 8:30AM
Registration, Coffee & Tea (4th Floor)
8:30AM - 8:35AM
Co-Chairs' Opening Remarks
Speakers:
Ann Daugherty, PhD, Senior Manager, Genentech
Mark Schiebler, PhD, Global Search and Evaluation Lead for Research Technologies, F. Hoffman La Roche
8:35AM - 9:00AM
Roche’s Industry Overview on the Drug Delivery Landscape 2023
Speakers:
Mark Schiebler, PhD, Global Search and Evaluation Lead for Research Technologies, F. Hoffman La Roche
Showing Events in 1 Track from 09:00am to 09:30pm
KEYNOTE
9:00AM - 9:30PM
Annual Keynote with MIT’s Dr Robert Langer
Speaker:
Robert Langer, PhD, David H. Koch Institute Professor, MIT
Moderated by:
Stéphane Bancel, MBA, CEO, Moderna
Media:
Showing Events in 1 Track from 09:30am to 10:15pm
Morning Sessions
9:30AM - 10:00AM
AI/ML: Using Computational Biology to Design Better Drug Delivery Systems and Discover Better Targets
Moderated by:
Annette Bak, PhD, MBA, Head of Advanced Drug Delivery, AstraZeneca
Panelists:
Lovisa Afzelius, PhD, MBA, Origination Partner, Flagship Pioneering
Vikram Agarwal, PhD, Head of mRNA Platform Design Data Science, Sanofi
John Quackenbush, PhD, Henry Pickering Walcott Professor of Computational Biology & Biostatistics, Harvard TH Chan School of Public Health
Daniel Reker, PhD, Assistant Professor of Biomedical Engineering, Duke University
10:00AM - 10:15PM
Time-To-Market: An Obvious Yet Perpetual Challenge
Speakers:
Clare Beddoes, PhD, Head of Drug Delivery, Cambridge Design Partnership
Showing Events in 1 Track from 10:15am to 11:05am
PODD Grand Opening Networking Break & Partnering
10:15AM - 11:05AM
PODD Grand Opening Networking Break & Partnering
Graciously hosted by:
Showing Events in 1 Track from 11:05am to 11:30am
Sustainability Keynote
11:05AM - 11:30AM
Sustainability Keynote - Laying a Path for a More Sustainable Future in the Device R&D Space
Speakers:
Ann Daugherty, PhD, Senior Manager, Genentech
Marianne Ølholm, DVM, PhD, DMSc, Senior Vice President, Devices & Delivery Solutions, Novo Nordisk
Showing Events in 1 Track from 11:30am to 12:30pm
Morning Second Session
11:30AM - 11:45AM
De-Risking Combination Product Development to Support Biocompatibility and Minimize Development Timelines
Speakers:
Yitian Xiao, Scientific Business Development Leader, BD Medical
11:45AM - 12:15PM
13th Annual Pharma Company Spotlights
Speakers:
Annette Bak, PhD, MBA, Head of Advanced Drug Delivery, AstraZeneca
Sherri Biondi, PhD, Senior Director and Head of Device Development, AstraZeneca
Ester Caffarel-Salvador, PhD, Associate Director, Strategic Innovation, Rare Diseases, Chiesi USA
Jim MacKrell, PhD, Associate Vice President & Head of East Coast (US) Venture Science - Lilly New Ventures, Eli Lilly and Company
With:
12:15PM - 12:30PM
Lost in Translation: Interpreting Between Science, Design and Manufacturing of Platform Drug Delivery Devices
Speakers:
Tony Bedford, Commercial Director, Platform Management & Innovation, Phillips-Medisize
Showing Events in 1 Track from 12:30pm to 01:40pm
Luncheon & Partnering Meetings 3rd Floor
12:30PM - 1:40PM
Luncheon & Partnering Meetings
Showing Events in 4 Tracks from 01:55pm to 03:55pm
Track 1A: Injectable Formulations & Polymers America South
Chaired by:
Srini Sridharan, PhD, Executive Director, Drug Delivery & Product Integration, Bristol-Myers Squibb
1:55PM - 2:10PM
Container Closure Integrity Phenomenology and Failure Mechanisms During Deep Cold Storage
Speakers:
Sukanya Murali, PhD, Technical Services Manager, Key Accounts, BD
2:10PM - 2:25PM
SynBiosys®: Long-Acting Injectable Microspheres & In Situ Forming Depots for Delivery of Small Molecules & Biologics
Speakers:
Rob Steendam, PhD, Chief Technology Officer, InnoCore Pharmaceuticals
2:25PM - 2:40PM
Apisolex™ Polymer: A New Enabling Tool for Insoluble Injectables – Simple Processing, High Drug Loading, and Lifecycle Management
Speakers:
Robert Lee, President, CDMO Division, Lubrizol Life Science
2:40PM - 2:55PM
A Novel Surfactant Dramatically Increasing the Stability and Concentration of Biologic Formulations
Speakers:
Bryan Mazlish, CEO, Surf Bio
2:55PM - 3:10PM
PharmaShell – New Possibilities for Long-Acting Injectable Formulations
Speakers:
David Westberg, CEO, Nanexa
3:10PM - 3:25PM
XeriJect™: Enabling Subcutaneous Delivery of High-Concentration Monoclonal Antibodies
Speakers:
Rick Fitch, PhD, Senior Director, Nonclinical Research & Development, Xeris Pharmaceuticals
3:25PM - 3:40PM
Scale-Up Challenges and Solutions for Long-Acting Injectables
Speakers:
Colin Spencer, Head of Technology Transfer, Project Manager, Oakwood Labs
3:40PM - 3:47PM
Pendant Functionalized Polymers: Boldly Going Where No PLGA Has Gone Before
Speakers:
C Eric Elmquist, PhD, COO of R&D, Pendant Biosciences
3:47PM - 3:55PM
SQore™ Enabled High Concentration mAb Formulations for Patient-Delivered Subcutaneous Delivery
Speakers:
Yuhong Zeng, PhD, Director of Formulation, Comera Life Sciences
Track 1B: Oral, Mucosal, Nasal and Other Non-Injectable Technologies
Chaired by:
Sarah Tao, PhD, Head of External Innovation, Biologics and Small Molecules Sanofi Partnering, Global Business Development and Licensing, Sanofi
1:55PM - 2:10PM
Nasal Routes Explored: Diving into Intranasal Delivery and Essential Aspects
Speakers:
Reenal Gandhi, Director, Business Development, Aptar Pharma
2:10PM - 2:25PM
Apinovex™ Polymer: A New Tool for Oral Solubility Enhancement, Improved Patient Experience and Lifecycle Management
Speakers:
Nick DiFranco, MEM, Global Market Manager, Oral Drug Delivery, Lubrizol Life Science
2:25PM - 2:40PM
Multiparticulates – A Versatile Tool For Patient-Centric Fixed Dose Combination Applications
Speakers:
Srinivasan Shanmugam, PhD, Executive Director, Pharmaceutical Sciences, Business Support & New Technologies, Adare Pharma Solutions
2:40PM - 2:55PM
Controlling Drug Release Rate and Location Through 3D Printed Dosage Forms
Speakers:
Timothy Tracy, PhD, Senior Advisor, Triastek
2:55PM - 3:10PM
Best Practices for Optimizing Route of Delivery for Improving Drug Development Outcomes
Speakers:
Ryan Doxey, Director, Technical Services, Kymanox
Stefanie Johns, PhD, Director, Regulatory Affairs, Kymanox
3:10PM - 3:25PM
BIONDD™ – Oral Delivery of Biologics – Effective Transitioning Injectables to a Capsule
Speakers:
Karsten Lindhardt, MSc, PhD, DBE, CEO and Founder, Biograil ApS
3:25PM - 3:40PM
SpraySol – A Solution for NCE’s with Low Bioavailability
Speakers:
Usha Pillai, PhD, PMP, PhD, PMP, Pharmacin
3:40PM - 3:47PM
Solving the Insoluble – A Eutectic Approach to Enhancing Oral Bioavailability
Speakers:
Niall Hodgins, Co-Founder & CEO, SeraNovo
3:47PM - 3:55PM
Can Spraying be Precise? Introducing SPRACISE® – a Novel Platform for Localized Deep Nasal Delivery.
Speakers:
Oren Berkowitz, PhD, Clinical Lead, Clexio
Track 1C: Connected Devices, Wearables & Other Novel Devices
Chaired by:
Cameron Lee, PhD, Associate Director, Novartis Institutes for BioMedical Research
1:55PM - 2:10PM
New Perspectives on Nanoparticle Platforms for Navigating Genetic Nanomedicine Through Regulatory Pathways
Speakers:
Anthony Duong, PhD, Principle Research Scientist, Battelle
2:10PM - 2:25PM
A Novel Prefilled Drug Delivery Platform: Expanding Access and Distribution
Speakers:
Bo Kowalczyk, MBA, Chief Commercial Officer, ApiJect
2:25PM - 2:40PM
Designing for Human Nature: What Makes a Truly Engaging Drug Delivery Solution?
Speakers:
Dan Lock, Design Insight & Strategy Lead, TTP
2:40PM - 2:55PM
Double Development, Double Speed
Speakers:
Matthew Fordham, Deputy Head of Drug Delivery & Head of Client Management, Cambridge Design Partnership
2:55PM - 3:10PM
Scalable, Translatable, Dependable – Renishaw’s Delivery Platform for Drugs & Biologics
Speakers:
Stuart Campbell, Clinical Sales & Business Development Manager, Renishaw
3:10PM - 3:25PM
Revolutionary Gas-Powered Auto-injector Platform for All Drug Viscosities and Volumes
Speakers:
Matt McCawley, CTO, Altaviz, Picocyl
3:25PM - 3:40PM
The LTS Sorrel Platform – Solving Dilemmas in the Fill/Finish Process
Speakers:
Greg Moakes, PhD, MBA, Executive Vice President, Business Development, Sorrel Platform, LTS Lohmann Therapie-Systeme AG, LTS Device Technologies
3:40PM - 3:47PM
Next Generation Smart Needle-Free Drug Delivery Platform Targeting Frequent Injections in Remote Healthcare Setting
Speakers:
Alina Su, PhD, Founder & CEO, NovaXS
3:47PM - 3:55PM
A Rugged, Reliable, Portable, Safe and Simple Auto-Injector
Speakers:
Conor Cullinane, PhD, President & CEO, Pirouette Medical
Track 1D: Cell & Gene Delivery
Chaired by:
Ashoka Madduri, PhD, MBA, Head of Scientific Strategy & Competitive Intelligence, mRNA Center of Excellence, Sanofi
1:55PM - 2:10PM
Biodegradable Lipid Nanoparticles for Gene Therapy and Vaccines with Room Temperature Stability
Speakers:
Sakura Taneichi, Research Scientist, NOF Corporation
2:10PM - 2:25PM
Advances in Nanotechnologies for Delivery of Biologics and Small Molecules
Speakers:
Shaukat Ali, PhD, Senior Director, Scientific Affairs & Technical Marketing, Ascendia Pharmaceuticals
2:25PM - 2:40PM
SORT LNP-formulated mRNA for the Treatment of Primary Ciliary Dyskinesia
Speakers:
Brandon Wustman, PhD, Senior Vice President, Research, ReCode Therapeutics
2:40PM - 2:55PM
Pioneering Programmable Medicines
Speakers:
Stuart Milstein, PhD, Chief Platform Officer, Senda Biosciences
2:55PM - 3:10PM
Establishing a Robust Process Control Strategy for NA-LNPs
Speakers:
Antonio Costa, PhD, CEO, DIANT Pharma
3:10PM - 3:25PM
Choosing the Right Microfluidic Mixing Platform: How Critical is This First Step Towards the Clinic?
Speakers:
Nicholas Boylan, PhD, Director, Nucleic Acid Delivery, Phosphorex
3:25PM - 3:40PM
Ushering in the New Era of Genetic Medicine with the Fusogenix Proteo-Lipid Vehicle Delivery Platform
3:40PM - 3:47PM
Dose-Adjustable Gene Therapy Platform Technology – Prometheus
Speakers:
Alex Goraltchouk, MBA, COO, Remedium Bio
3:52PM - 3:55PM
Immuno-LNP Delivers Diverse Therapeutic Payloads Across the BBB
Speakers:
Joe Harford, PhD, President & CEO, SynerGene Therapeutics
Showing Events in 1 Track from 03:55pm to 04:10pm
Break
3:55PM - 4:10PM
15-Minute Ice-Cream Break (3rd Floor)
Graciously Hosted by:
Showing Events in 4 Tracks from 04:15pm to 06:30pm
Track 1B: Self-Injection Devices, Syringes, Primary Container & Packaging Solutions
Chaired by:
Sherri Biondi, PhD, Senior Director and Head of Device Development, AstraZeneca
4:15PM - 4:30PM
A Novel Method to Optimizing Drug Delivery for Parenteral Products Involving New Therapies and Unmet Needs
Speakers:
Asmita Khanolkar, Senior Director, SMC LTD
4:30PM - 4:45PM
Molly Connected Cap Shapes Pharma’s Digital Health Path with Innovation Partnerships
Speakers:
Nagisa Kobashi, Product Manager for Global Emerging Technology & Digital Health, SHL Medical
4:45PM - 5:00PM
De-Risking Combination Product Programs Through a Collaborations’ Integrated Device Approach From Primary Package to Final Assembly
Speakers:
Josh Gordon, Product Manager, Auto-Injectors, Stevanato Group
5:00PM - 5:15PM
Addressing Unsolved Autoinjector Needs is Key to Enable Administration of High-Dose Biologics
Speakers:
Gaurtam Shetty, PhD, Founder & CEO, Congruence Medical Solutions
5:15PM - 5:30PM
Syringe System Innovation Driving Evolution Of Dual-Chamber Prefilled Syringe System Design, Development & Manufacturing
Speakers:
Laxman Halleppanavar, Director - Commercial Engineering Project Management, Credence Medsystems
5:30PM - 5:45PM
Technical & Human Factors Considerations for High Viscosity/High Volume Injection
Speakers:
Michael Roe, PE, Senior Director, Development & Industrialization, Kaléo
5:45PM - 6:00PM
Maximizing the Value Your Material Supplier Can Bring to Your Drug Delivery Device Design for Precision Friction Performance
Speakers:
Don DeMello, Principal Application Development Engineer - Medical, Celanese
6:00PM - 6:15PM
Ypsomed’s Approach to the Growing Market for Injection Device Solutions
Speakers:
Philipp Richard, MBA, Account & Business Development Manager, Ypsomed
Track 2B: Injectable & Non-Injectable Formulation Technologies
Chaired by:
Sudhakar Garad, PhD, Global Head of Chemical and Pharmaceutical Profiling, NIBR
4:15PM - 4:30PM
Polymeric Drug Delivery Technology for Sustained Release of Small and Large Molecules
Speakers:
Keith Henry, MBA, New Business Development Leader, Celanese
4:30PM - 4:45PM
From Micro to Nano: Block Copolymers Enable Nanoparticle Drug Products for the Treatment of New Therapeutic Modalities
Speakers:
Whitney Beysselance Moro, PhD, Director, Strategic & Technical Marketing, Evonik
4:45PM - 5:00PM
The Viscosity Reduction Platform: An Excipient Portfolio Enabling Reduction of Viscosity While Maintaining Protein Stability
Speakers:
Lydon Salins, PhD, Technical Application Manager, Biomolecule/Liquid Formulation, Millipore Sigma
5:00PM - 5:15PM
Overcoming Challenges with Formulation of Nucleophilic APIs in the Development of Long-Acting Therapies
Speakers:
George Mihov, PhD, Principal Scientist - Drug Delivery Solutions, DSM Biomedical
5:15PM - 5:30PM
PURASORB® Lactide-Glycolide Bioresorbable Copolymers for Creating Effective Long-Acting Injectables
Speakers:
Julien Bérard, MBA, Global Director, Business Development Biomaterials, Corbion
5:30PM - 5:45PM
BEPO Technology: Addressing Patient Needs Through Best-In-Class Long-Acting Injectables
Speakers:
Christophe Roberge, PhD, Partnering Director, Senior Expert Science & Technology, MedinCell
5:45PM - 6:00PM
Benefits of Diffusion-Based Implantable Drug Delivery Technology for Long-Term Delivery Windows (6-12 mo.) Mediated via Porous Media
Speakers:
Alex Hill, Senior Research Scientist, Mott Corporation
6:00PM - 6:07PM
Robust Delivery of Biologics with Novel DELOS Nanovesicles
Speakers:
Alba Córdoba, PhD, Tech Transfer & Business Development Director, Nanomol Technologies
6:07PM - 6:15PM
Revolutionizing Antiviral Treatments – Orally Available Nanomedicines that Can Also Deliver Difficult APIs and Improve Their PK
Speakers:
Anil Diwan, PhD, President & Exectuive Chairman, Nanoviricides
Track 3B: Connected Devices, Wearables & Other Novel Devices
Chaired by:
Ulrich Brüggemann, Lead Advanced Drug Delivery Technical Development, Takeda Pharmaceuticals
4:15PM - 4:30PM
Revolutionizing Injectable Therapies: Overcoming Key Challenges in Drug Delivery with a Needle-Free and Connected Solution
Speakers:
Veena Rao, PhD, President & Chief Business Officer, Portal Instruments
4:30PM - 4:45PM
Advancements in Micro Molding for Drug Delivery – What is Now Possible
Speakers:
Brent Hahn, MBA, VP, Business Development & Strategy, Isometric Micro Molding
4:45PM - 5:00PM
How Pharma Can Avoid Creating Dysfunctional Connected Device Development Programs & Organizations
Speakers:
Jim McGough, Co-Founder & Director, EdgeOne Medical
5:00PM - 5:15PM
Halozyme’s ENHANZE Drug Delivery Technology Enables Rapid High Volume Subcutaneous Drug Delivery Expanding Autoinjector
Speakers:
Michael LaBarre, PhD, Chief Technical Officer, Halozyme
5:15PM - 5:30PM
What’s Beyond 10mL? Unique Learnings in Large Volume Subcutaneous Infusion
Speakers:
Josh Bennett, General Manager of Novel Therapies, Koru Medical
5:30PM - 5:45PM
Potential Financial Cost Implications When Developing a Connected Drug Delivery Device, Versus a Non-Connected Product
Speakers:
Chris Hurlstone, Technical Director, Team Consulting
5:45PM - 6:00PM
How to Better Deal With the Challenges of Mixing & Delivering Highly Viscous Drugs
Speakers:
Claire Authesserre, PhD, Project Manager, Eveon
6:00PM - 6:15PM
Accelerating Development of User-Driven Connected Devices & Combination Products
Speakers:
Mark Tunkel, Global Category Director, Services, Nemera
6:15PM - 6:22PM
Reimagining the Potential of Intradermal Delivery with a Novel Injection Platform
Speakers:
Nicky Bertollo, PhD, Co-Founder & CTO, Pharma Latch
6:22PM - 6:30PM
Revolutionizing Drug Delivery to Challenging Brain Regions for a Diverse Range of Therapeutics & Localized Brain Conditions
Speakers:
Paul Schultz, SVP, Business Development, Bionaut Labs
Track 4B: Cell, Gene & Other Biologics Delivery
Chaired by:
Andrew Kroetsch, PhD, Associate Director, Takeda Pharmaceuticals
4:15PM - 4:30PM
The Potential of Eliminating Cold Chain Storage for Vaccine Distribution & Delivery
Speakers:
Mike Ratigan, Commercial Head, Advanced Pulmonary Delivery, Kindeva Drug Delivery
4:30PM - 4:45PM
Redefining Non-Viral Delivery for Novel Genomic Medicines with Hopewell’s Tissue-Targeted Lipid Nanoparticle (ttLNP) Platformn
Speakers:
Kate Zhang, PhD, Chief Scientific Officer, Hopewell Therapeutics
4:45PM - 5:00PM
Modulating Neutrophil Activity in Disease Using Targeted mRNA and Small Molecule Delivery
5:00PM - 5:15PM
BactPac™: A Bacteria-based Drug Delivery Platform to Enable the Next Generation of Nucleic Acid and Gene Therapies
Speakers:
Ashley Williams, PhD, Director of Research & Development, SiVec Biotechnologies
5:15PM - 5:30PM
Sustained Release Biologic Implants for the Treatment of Retinal Disease
Speakers:
Patrick Ruane, PhD, Chief Operating Officer, Re-Vana Therapeutics
5:30PM - 5:45PM
Turning Implantable Devices into Therapeutic Treatments: Ushering in the Next Evolution in Targeted Therapies
Speakers:
Luis Alvarez, PhD, Founder & CEO, Theradaptive
Showing Events in 1 Track from 06:30pm to 07:35pm
Networking
6:30PM - 7:30PM
PODD Networking Reception & Partnering Meetings
Graciously Hosted by:
7:30PM - 7:35PM
Day One Concludes
Showing Events in 1 Track from 08:00am to 09:00am
Morning General Session
8:00AM - 8:30AM
Registration, Coffee & Tea (4th Floor)
8:30AM - 8:35AM
Co-Chairs' Opening Remarks
Speakers:
Ann Daugherty, PhD, Senior Manager, Genentech
Mark Schiebler, PhD, Global Search and Evaluation Lead for Research Technologies, F. Hoffman La Roche
8:35AM - 9:00AM
Roche’s Industry Overview on the Drug Delivery Landscape 2023
Speakers:
Mark Schiebler, PhD, Global Search and Evaluation Lead for Research Technologies, F. Hoffman La Roche
Showing Events in 1 Track from 09:00am to 09:30pm
KEYNOTE
9:00AM - 9:30PM
Annual Keynote with MIT’s Dr Robert Langer
Speaker:
Robert Langer, PhD, David H. Koch Institute Professor, MIT
Moderated by:
Stéphane Bancel, MBA, CEO, Moderna
Media:
Showing Events in 1 Track from 09:30am to 10:15pm
Morning Sessions
9:30AM - 10:00AM
AI/ML: Using Computational Biology to Design Better Drug Delivery Systems and Discover Better Targets
Moderated by:
Annette Bak, PhD, MBA, Head of Advanced Drug Delivery, AstraZeneca
Panelists:
Lovisa Afzelius, PhD, MBA, Origination Partner, Flagship Pioneering
Vikram Agarwal, PhD, Head of mRNA Platform Design Data Science, Sanofi
John Quackenbush, PhD, Henry Pickering Walcott Professor of Computational Biology & Biostatistics, Harvard TH Chan School of Public Health
Daniel Reker, PhD, Assistant Professor of Biomedical Engineering, Duke University
10:00AM - 10:15PM
Time-To-Market: An Obvious Yet Perpetual Challenge
Speakers:
Clare Beddoes, PhD, Head of Drug Delivery, Cambridge Design Partnership
Showing Events in 1 Track from 10:15am to 11:05am
PODD Grand Opening Networking Break & Partnering
10:15AM - 11:05AM
PODD Grand Opening Networking Break & Partnering
Graciously hosted by:
Showing Events in 1 Track from 11:05am to 11:30am
Sustainability Keynote
11:05AM - 11:30AM
Sustainability Keynote - Laying a Path for a More Sustainable Future in the Device R&D Space
Speakers:
Ann Daugherty, PhD, Senior Manager, Genentech
Marianne Ølholm, DVM, PhD, DMSc, Senior Vice President, Devices & Delivery Solutions, Novo Nordisk
Showing Events in 1 Track from 11:30am to 12:30pm
Morning Second Session
11:30AM - 11:45AM
De-Risking Combination Product Development to Support Biocompatibility and Minimize Development Timelines
Speakers:
Yitian Xiao, Scientific Business Development Leader, BD Medical
11:45AM - 12:15PM
13th Annual Pharma Company Spotlights
Speakers:
Annette Bak, PhD, MBA, Head of Advanced Drug Delivery, AstraZeneca
Sherri Biondi, PhD, Senior Director and Head of Device Development, AstraZeneca
Ester Caffarel-Salvador, PhD, Associate Director, Strategic Innovation, Rare Diseases, Chiesi USA
Jim MacKrell, PhD, Associate Vice President & Head of East Coast (US) Venture Science - Lilly New Ventures, Eli Lilly and Company
With:
12:15PM - 12:30PM
Lost in Translation: Interpreting Between Science, Design and Manufacturing of Platform Drug Delivery Devices
Speakers:
Tony Bedford, Commercial Director, Platform Management & Innovation, Phillips-Medisize
Showing Events in 1 Track from 12:30pm to 01:40pm
Luncheon & Partnering Meetings
3rd Floor
12:30PM - 1:40PM
Luncheon & Partnering Meetings
Showing Events in 4 Tracks from 01:55pm to 03:55pm
Track 1A: Injectable Formulations & Polymers
America South
Chaired by:
Srini Sridharan, PhD, Executive Director, Drug Delivery & Product Integration, Bristol-Myers Squibb
1:55PM - 2:10PM
Container Closure Integrity Phenomenology and Failure Mechanisms During Deep Cold Storage
Speakers:
Sukanya Murali, PhD, Technical Services Manager, Key Accounts, BD
2:10PM - 2:25PM
SynBiosys®: Long-Acting Injectable Microspheres & In Situ Forming Depots for Delivery of Small Molecules & Biologics
Speakers:
Rob Steendam, PhD, Chief Technology Officer, InnoCore Pharmaceuticals
2:25PM - 2:40PM
Apisolex™ Polymer: A New Enabling Tool for Insoluble Injectables – Simple Processing, High Drug Loading, and Lifecycle Management
Speakers:
Robert Lee, President, CDMO Division, Lubrizol Life Science
2:40PM - 2:55PM
A Novel Surfactant Dramatically Increasing the Stability and Concentration of Biologic Formulations
Speakers:
Bryan Mazlish, CEO, Surf Bio
2:55PM - 3:10PM
PharmaShell – New Possibilities for Long-Acting Injectable Formulations
Speakers:
David Westberg, CEO, Nanexa
3:10PM - 3:25PM
XeriJect™: Enabling Subcutaneous Delivery of High-Concentration Monoclonal Antibodies
Speakers:
Rick Fitch, PhD, Senior Director, Nonclinical Research & Development, Xeris Pharmaceuticals
3:25PM - 3:40PM
Scale-Up Challenges and Solutions for Long-Acting Injectables
Speakers:
Colin Spencer, Head of Technology Transfer, Project Manager, Oakwood Labs
3:40PM - 3:47PM
Pendant Functionalized Polymers: Boldly Going Where No PLGA Has Gone Before
Speakers:
C Eric Elmquist, PhD, COO of R&D, Pendant Biosciences
3:47PM - 3:55PM
SQore™ Enabled High Concentration mAb Formulations for Patient-Delivered Subcutaneous Delivery
Speakers:
Yuhong Zeng, PhD, Director of Formulation, Comera Life Sciences
Track 1B: Oral, Mucosal, Nasal and Other Non-Injectable Technologies
Chaired by:
Sarah Tao, PhD, Head of External Innovation, Biologics and Small Molecules Sanofi Partnering, Global Business Development and Licensing, Sanofi
1:55PM - 2:10PM
Nasal Routes Explored: Diving into Intranasal Delivery and Essential Aspects
Speakers:
Reenal Gandhi, Director, Business Development, Aptar Pharma
2:10PM - 2:25PM
Apinovex™ Polymer: A New Tool for Oral Solubility Enhancement, Improved Patient Experience and Lifecycle Management
Speakers:
Nick DiFranco, MEM, Global Market Manager, Oral Drug Delivery, Lubrizol Life Science
2:25PM - 2:40PM
Multiparticulates – A Versatile Tool For Patient-Centric Fixed Dose Combination Applications
Speakers:
Srinivasan Shanmugam, PhD, Executive Director, Pharmaceutical Sciences, Business Support & New Technologies, Adare Pharma Solutions
2:40PM - 2:55PM
Controlling Drug Release Rate and Location Through 3D Printed Dosage Forms
Speakers:
Timothy Tracy, PhD, Senior Advisor, Triastek
2:55PM - 3:10PM
Best Practices for Optimizing Route of Delivery for Improving Drug Development Outcomes
Speakers:
Ryan Doxey, Director, Technical Services, Kymanox
Stefanie Johns, PhD, Director, Regulatory Affairs, Kymanox
3:10PM - 3:25PM
BIONDD™ – Oral Delivery of Biologics – Effective Transitioning Injectables to a Capsule
Speakers:
Karsten Lindhardt, MSc, PhD, DBE, CEO and Founder, Biograil ApS
3:25PM - 3:40PM
SpraySol – A Solution for NCE’s with Low Bioavailability
Speakers:
Usha Pillai, PhD, PMP, PhD, PMP, Pharmacin
3:40PM - 3:47PM
Solving the Insoluble – A Eutectic Approach to Enhancing Oral Bioavailability
Speakers:
Niall Hodgins, Co-Founder & CEO, SeraNovo
3:47PM - 3:55PM
Can Spraying be Precise? Introducing SPRACISE® – a Novel Platform for Localized Deep Nasal Delivery.
Speakers:
Oren Berkowitz, PhD, Clinical Lead, Clexio
Track 1C: Connected Devices, Wearables & Other Novel Devices
Chaired by:
Cameron Lee, PhD, Associate Director, Novartis Institutes for BioMedical Research
1:55PM - 2:10PM
New Perspectives on Nanoparticle Platforms for Navigating Genetic Nanomedicine Through Regulatory Pathways
Speakers:
Anthony Duong, PhD, Principle Research Scientist, Battelle
2:10PM - 2:25PM
A Novel Prefilled Drug Delivery Platform: Expanding Access and Distribution
Speakers:
Bo Kowalczyk, MBA, Chief Commercial Officer, ApiJect
2:25PM - 2:40PM
Designing for Human Nature: What Makes a Truly Engaging Drug Delivery Solution?
Speakers:
Dan Lock, Design Insight & Strategy Lead, TTP
2:40PM - 2:55PM
Double Development, Double Speed
Speakers:
Matthew Fordham, Deputy Head of Drug Delivery & Head of Client Management, Cambridge Design Partnership
2:55PM - 3:10PM
Scalable, Translatable, Dependable – Renishaw’s Delivery Platform for Drugs & Biologics
Speakers:
Stuart Campbell, Clinical Sales & Business Development Manager, Renishaw
3:10PM - 3:25PM
Revolutionary Gas-Powered Auto-injector Platform for All Drug Viscosities and Volumes
Speakers:
Matt McCawley, CTO, Altaviz, Picocyl
3:25PM - 3:40PM
The LTS Sorrel Platform – Solving Dilemmas in the Fill/Finish Process
Speakers:
Greg Moakes, PhD, MBA, Executive Vice President, Business Development, Sorrel Platform, LTS Lohmann Therapie-Systeme AG, LTS Device Technologies
3:40PM - 3:47PM
Next Generation Smart Needle-Free Drug Delivery Platform Targeting Frequent Injections in Remote Healthcare Setting
Speakers:
Alina Su, PhD, Founder & CEO, NovaXS
3:47PM - 3:55PM
A Rugged, Reliable, Portable, Safe and Simple Auto-Injector
Speakers:
Conor Cullinane, PhD, President & CEO, Pirouette Medical
Track 1D: Cell & Gene Delivery
Chaired by:
Ashoka Madduri, PhD, MBA, Head of Scientific Strategy & Competitive Intelligence, mRNA Center of Excellence, Sanofi
1:55PM - 2:10PM
Biodegradable Lipid Nanoparticles for Gene Therapy and Vaccines with Room Temperature Stability
Speakers:
Sakura Taneichi, Research Scientist, NOF Corporation
2:10PM - 2:25PM
Advances in Nanotechnologies for Delivery of Biologics and Small Molecules
Speakers:
Shaukat Ali, PhD, Senior Director, Scientific Affairs & Technical Marketing, Ascendia Pharmaceuticals
2:25PM - 2:40PM
SORT LNP-formulated mRNA for the Treatment of Primary Ciliary Dyskinesia
Speakers:
Brandon Wustman, PhD, Senior Vice President, Research, ReCode Therapeutics
2:40PM - 2:55PM
Pioneering Programmable Medicines
Speakers:
Stuart Milstein, PhD, Chief Platform Officer, Senda Biosciences
2:55PM - 3:10PM
Establishing a Robust Process Control Strategy for NA-LNPs
Speakers:
Antonio Costa, PhD, CEO, DIANT Pharma
3:10PM - 3:25PM
Choosing the Right Microfluidic Mixing Platform: How Critical is This First Step Towards the Clinic?
Speakers:
Nicholas Boylan, PhD, Director, Nucleic Acid Delivery, Phosphorex
3:25PM - 3:40PM
Ushering in the New Era of Genetic Medicine with the Fusogenix Proteo-Lipid Vehicle Delivery Platform
3:40PM - 3:47PM
Dose-Adjustable Gene Therapy Platform Technology – Prometheus
Speakers:
Alex Goraltchouk, MBA, COO, Remedium Bio
3:52PM - 3:55PM
Immuno-LNP Delivers Diverse Therapeutic Payloads Across the BBB
Speakers:
Joe Harford, PhD, President & CEO, SynerGene Therapeutics
Showing Events in 1 Track from 03:55pm to 04:10pm
Break
3:55PM - 4:10PM
15-Minute Ice-Cream Break (3rd Floor)
Graciously Hosted by:
Showing Events in 4 Tracks from 04:15pm to 06:30pm
Track 1B: Self-Injection Devices, Syringes, Primary Container & Packaging Solutions
Chaired by:
Sherri Biondi, PhD, Senior Director and Head of Device Development, AstraZeneca
4:15PM - 4:30PM
A Novel Method to Optimizing Drug Delivery for Parenteral Products Involving New Therapies and Unmet Needs
Speakers:
Asmita Khanolkar, Senior Director, SMC LTD
4:30PM - 4:45PM
Molly Connected Cap Shapes Pharma’s Digital Health Path with Innovation Partnerships
Speakers:
Nagisa Kobashi, Product Manager for Global Emerging Technology & Digital Health, SHL Medical
4:45PM - 5:00PM
De-Risking Combination Product Programs Through a Collaborations’ Integrated Device Approach From Primary Package to Final Assembly
Speakers:
Josh Gordon, Product Manager, Auto-Injectors, Stevanato Group
5:00PM - 5:15PM
Addressing Unsolved Autoinjector Needs is Key to Enable Administration of High-Dose Biologics
Speakers:
Gaurtam Shetty, PhD, Founder & CEO, Congruence Medical Solutions
5:15PM - 5:30PM
Syringe System Innovation Driving Evolution Of Dual-Chamber Prefilled Syringe System Design, Development & Manufacturing
Speakers:
Laxman Halleppanavar, Director - Commercial Engineering Project Management, Credence Medsystems
5:30PM - 5:45PM
Technical & Human Factors Considerations for High Viscosity/High Volume Injection
Speakers:
Michael Roe, PE, Senior Director, Development & Industrialization, Kaléo
5:45PM - 6:00PM
Maximizing the Value Your Material Supplier Can Bring to Your Drug Delivery Device Design for Precision Friction Performance
Speakers:
Don DeMello, Principal Application Development Engineer - Medical, Celanese
6:00PM - 6:15PM
Ypsomed’s Approach to the Growing Market for Injection Device Solutions
Speakers:
Philipp Richard, MBA, Account & Business Development Manager, Ypsomed
Track 2B: Injectable & Non-Injectable Formulation Technologies
Chaired by:
Sudhakar Garad, PhD, Global Head of Chemical and Pharmaceutical Profiling, NIBR
4:15PM - 4:30PM
Polymeric Drug Delivery Technology for Sustained Release of Small and Large Molecules
Speakers:
Keith Henry, MBA, New Business Development Leader, Celanese
4:30PM - 4:45PM
From Micro to Nano: Block Copolymers Enable Nanoparticle Drug Products for the Treatment of New Therapeutic Modalities
Speakers:
Whitney Beysselance Moro, PhD, Director, Strategic & Technical Marketing, Evonik
4:45PM - 5:00PM
The Viscosity Reduction Platform: An Excipient Portfolio Enabling Reduction of Viscosity While Maintaining Protein Stability
Speakers:
Lydon Salins, PhD, Technical Application Manager, Biomolecule/Liquid Formulation, Millipore Sigma
5:00PM - 5:15PM
Overcoming Challenges with Formulation of Nucleophilic APIs in the Development of Long-Acting Therapies
Speakers:
George Mihov, PhD, Principal Scientist - Drug Delivery Solutions, DSM Biomedical
5:15PM - 5:30PM
PURASORB® Lactide-Glycolide Bioresorbable Copolymers for Creating Effective Long-Acting Injectables
Speakers:
Julien Bérard, MBA, Global Director, Business Development Biomaterials, Corbion
5:30PM - 5:45PM
BEPO Technology: Addressing Patient Needs Through Best-In-Class Long-Acting Injectables
Speakers:
Christophe Roberge, PhD, Partnering Director, Senior Expert Science & Technology, MedinCell
5:45PM - 6:00PM
Benefits of Diffusion-Based Implantable Drug Delivery Technology for Long-Term Delivery Windows (6-12 mo.) Mediated via Porous Media
Speakers:
Alex Hill, Senior Research Scientist, Mott Corporation
6:00PM - 6:07PM
Robust Delivery of Biologics with Novel DELOS Nanovesicles
Speakers:
Alba Córdoba, PhD, Tech Transfer & Business Development Director, Nanomol Technologies
6:07PM - 6:15PM
Revolutionizing Antiviral Treatments – Orally Available Nanomedicines that Can Also Deliver Difficult APIs and Improve Their PK
Speakers:
Anil Diwan, PhD, President & Exectuive Chairman, Nanoviricides
Track 3B: Connected Devices, Wearables & Other Novel Devices
Chaired by:
Ulrich Brüggemann, Lead Advanced Drug Delivery Technical Development, Takeda Pharmaceuticals
4:15PM - 4:30PM
Revolutionizing Injectable Therapies: Overcoming Key Challenges in Drug Delivery with a Needle-Free and Connected Solution
Speakers:
Veena Rao, PhD, President & Chief Business Officer, Portal Instruments
4:30PM - 4:45PM
Advancements in Micro Molding for Drug Delivery – What is Now Possible
Speakers:
Brent Hahn, MBA, VP, Business Development & Strategy, Isometric Micro Molding
4:45PM - 5:00PM
How Pharma Can Avoid Creating Dysfunctional Connected Device Development Programs & Organizations
Speakers:
Jim McGough, Co-Founder & Director, EdgeOne Medical
5:00PM - 5:15PM
Halozyme’s ENHANZE Drug Delivery Technology Enables Rapid High Volume Subcutaneous Drug Delivery Expanding Autoinjector
Speakers:
Michael LaBarre, PhD, Chief Technical Officer, Halozyme
5:15PM - 5:30PM
What’s Beyond 10mL? Unique Learnings in Large Volume Subcutaneous Infusion
Speakers:
Josh Bennett, General Manager of Novel Therapies, Koru Medical
5:30PM - 5:45PM
Potential Financial Cost Implications When Developing a Connected Drug Delivery Device, Versus a Non-Connected Product
Speakers:
Chris Hurlstone, Technical Director, Team Consulting
5:45PM - 6:00PM
How to Better Deal With the Challenges of Mixing & Delivering Highly Viscous Drugs
Speakers:
Claire Authesserre, PhD, Project Manager, Eveon
6:00PM - 6:15PM
Accelerating Development of User-Driven Connected Devices & Combination Products
Speakers:
Mark Tunkel, Global Category Director, Services, Nemera
6:15PM - 6:22PM
Reimagining the Potential of Intradermal Delivery with a Novel Injection Platform
Speakers:
Nicky Bertollo, PhD, Co-Founder & CTO, Pharma Latch
6:22PM - 6:30PM
Revolutionizing Drug Delivery to Challenging Brain Regions for a Diverse Range of Therapeutics & Localized Brain Conditions
Speakers:
Paul Schultz, SVP, Business Development, Bionaut Labs
Track 4B: Cell, Gene & Other Biologics Delivery
Chaired by:
Andrew Kroetsch, PhD, Associate Director, Takeda Pharmaceuticals
4:15PM - 4:30PM
The Potential of Eliminating Cold Chain Storage for Vaccine Distribution & Delivery
Speakers:
Mike Ratigan, Commercial Head, Advanced Pulmonary Delivery, Kindeva Drug Delivery
4:30PM - 4:45PM
Redefining Non-Viral Delivery for Novel Genomic Medicines with Hopewell’s Tissue-Targeted Lipid Nanoparticle (ttLNP) Platformn
Speakers:
Kate Zhang, PhD, Chief Scientific Officer, Hopewell Therapeutics
4:45PM - 5:00PM
Modulating Neutrophil Activity in Disease Using Targeted mRNA and Small Molecule Delivery
5:00PM - 5:15PM
BactPac™: A Bacteria-based Drug Delivery Platform to Enable the Next Generation of Nucleic Acid and Gene Therapies
Speakers:
Ashley Williams, PhD, Director of Research & Development, SiVec Biotechnologies
5:15PM - 5:30PM
Sustained Release Biologic Implants for the Treatment of Retinal Disease
Speakers:
Patrick Ruane, PhD, Chief Operating Officer, Re-Vana Therapeutics
5:30PM - 5:45PM
Turning Implantable Devices into Therapeutic Treatments: Ushering in the Next Evolution in Targeted Therapies
Speakers:
Luis Alvarez, PhD, Founder & CEO, Theradaptive
Showing Events in 1 Track from 06:30pm to 07:35pm
Networking
6:30PM - 7:30PM
PODD Networking Reception & Partnering Meetings
Graciously Hosted by:
7:30PM - 7:35PM
Day One Concludes
Previous
Day 1 October 16, 2023
Monday, October 16, 2023

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.